Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 3;12(1):18599.
doi: 10.1038/s41598-022-21977-9.

Inflammation mediates approximately one quarter of excess relative all-cause mortality in persons with rheumatoid arthritis: the Trøndelag Health Study

Affiliations

Inflammation mediates approximately one quarter of excess relative all-cause mortality in persons with rheumatoid arthritis: the Trøndelag Health Study

Vibeke Videm et al. Sci Rep. .

Abstract

Inflammation may contribute to excess mortality in rheumatoid arthritis (RA) patients. We investigated associations to all-cause mortality of the inflammation markers high-sensitivity C-reactive protein (CRP), lactoferrin (neutrophil activation marker), and neopterin (monocyte activation marker). From the population-based Trøndelag Health Study (3rd wave 2006-2008), 316 RA patients and 43,579 controls were included. Lactoferrin and neopterin were quantified in a nested cohort (n = 283 RA patients, n = 3698 controls). Follow-up was until death found by linkage to the Norwegian Cause of Death Registry or 31.12.2018. All-cause mortality was analyzed using Cox regression and Cox regression-based mediation analysis. Having RA (hazard ratio (HR): 1.25, 95%CI: 1.00, 1.56, p = 0.048), and CRP ≥ 3 mg/L (HR: 1.50, 95%CI: 1.41, 1.60, p < 0.001) were associated with all-cause mortality. The overall excess relative mortality risk of having RA was 38%. CRP ≥ 3 mg/L mediated approximately 1/4 of this risk (p < 0.001). In the nested cohort, CRP ≥ 3 mg/L (HR: 1.51, 95%CI: 1.26, 1.80, p < 0.001) and neopterin (HR: 1.17, 95%CI: 1.01, 1.36, p = 0.031) were associated with all-cause mortality. In conclusion, CRP levels ≥ 3 mg/L mediated approximately a quarter of the 38% excess relative all-cause mortality risk associated with RA. Using definitions of RA remission with emphasis both on joint status and the level of general inflammation may help guide the most efficient treatment regimens.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Participant inclusion and exclusion. Participants in the main analysis including C-reactive protein, and the nested cohort study including the biomarkers C-reactive protein, lactoferrin, and neopterin. Missing variables: C-reactive protein (1.5%), body mass index (0.8%), total cholesterol (2.9%), HDL cholesterol (2.9%), smoking (11.3%). HUNT3; 3rd wave of the Trøndelag Health Study (2006–2008).
Figure 2
Figure 2
Analytical models. Panel a: In Cox regression, the independent associations with all-cause mortality of each of the explanatory variables presence of rheumatoid arthritis and C-reactive protein concentration ≥ 3 mg/L were investigated. Panel b: In the mediation analysis, the direct association with all-cause mortality of rheumatoid arthritis was investigated (formula image), as well as the indirect effect of rheumatoid arthritis mediated by inflammation, using C-reactive protein concentration ≥ 3 mg/L as biomarker (formula image). Both final models were adjusted for body mass index, diabetes, hypertension, smoking, and total cholesterol.

References

    1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094–1108. doi: 10.1016/S0140-6736(10)60826-4. - DOI - PubMed
    1. Abhishek A, et al. Rheumatoid arthritis and excess mortality: Down but not out. A primary care cohort study using data from Clinical Practice Research Datalink. Rheumatol. (Oxf.) 2018;57:977–981. doi: 10.1093/rheumatology/key013. - DOI - PMC - PubMed
    1. Holmqvist M, Ljung L, Askling J. Mortality following new-onset rheumatoid arthritis: Has modern rheumatology had an impact? Ann. Rheum. Dis. 2018;77:85–91. doi: 10.1136/annrheumdis-2017-212131. - DOI - PubMed
    1. Ometto F, et al. Cause-specific mortality in a large population-based cohort of patients with rheumatoid arthritis in Italy. Clin. Exp. Rheumatol. 2018;36:636–642. - PubMed
    1. Houge IS, Hoff M, Thomas R, Videm V. Mortality is increased in patients with rheumatoid arthritis or diabetes compared to the general population—the Nord-Trøndelag Health Study. Sci. Rep. 2020;10:3593. doi: 10.1038/s41598-020-60621-2. - DOI - PMC - PubMed

Publication types